MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
PALI — Palisade Bio, Inc. Common Stock
NasdaqPalisade Bio, Inc. Common Stock
$1.48
-0.01(-0.67%)
- O
- 1.46
- H
- 1.48
- L
- 1.44
- V
- 825.22K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About PALI
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateApr 28, 2021
Employees14
Stock ExchangeNasdaq
Ticker SymbolPALI
Websitehttps://www.palisadebio.com
Key Financial Statistics
| Market Cap | $250.95M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.32 - $2.86 |
| 52-Week Avg Volume | 4.03M |
| VWAP | $1.47 |
| Transactions | 3,737 |
| Total Recorded Bars | 1,368 days |